New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

Russian attackers were behind the hack of the European Medicines Agency EMA in 2020. They had “unauthorized access to ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...

ANDEMBRY®, the first and only once-monthly treatment targeting factor XIIa to prevent attacks in HAE patients, inhibits plasma protein factor ...

Medicenna's financial statements for the three and nine months ended December 31, 2024, and the related management's discussion and analysis (MD&A) will be available on SEDAR+ at sedarplus.ca.

The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...

Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will ...

Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate ...